Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Suzetrigine bulk supplier for pharma manufacturers

Suzetrigine 50 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 50 mg

Reference Brands: Journavx(USA/EU)

Category: Neurology

Suzetrigine is a first-in-class non-opioid analgesic that selectively inhibits the NaV1.8 sodium channel in pain-sensing nerves. It is used for the management of moderate to severe acute pain in adults by reducing the transmission of pain signals from peripheral nerves to the central nervous system.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Suzetrigine — third party manufacturing & bulk supply

Suzetrigine 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Suzetrigine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Suzetrigine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Suzetrigine is an anticonvulsant used to treat partial-onset seizures in patients with epilepsy. It helps stabilize neuronal activity in the brain and reduce seizure frequency.

It is made from the active ingredient suzetrigine, a synthetic compound that modulates voltage-gated sodium channels and calcium channels in the nervous system.

The trade name is Suzetrigine.

It is manufactured by regulatory-approved pharmaceutical companies that produce epilepsy medications; the exact manufacturer may vary by region.

The generic name is Suzetrigine.

The brand name is Suzetrigine.

It is manufactured in approved pharmaceutical production facilities depending on the manufacturer, typically in countries with regulatory approval for epilepsy drugs.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.